Effects of nucleotides and nucleosides on coagulation

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 5, 2010, Pages 436-441

  Bune, Laurids T ^a   Thaning, Pia ^a   Johansson, Pär I ^b   Bochsen, Louise ^b   Rosenmeier, Jaya B ^a,c  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

ADP; ATP; nitric oxide; nucleotides; thromboelastography; tissue plasminogen activator; uridine triphosphate

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; NITRIC OXIDE; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE DERIVATIVE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; URIDINE TRIPHOSPHATE;

ARTICLE; BLOOD CLOTTING; CLINICAL ASSESSMENT; CONTROLLED STUDY; FIBRINOLYSIS; HEMOSTASIS; INDUCED HYPOTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SHOCK; SWINE; THROMBOELASTOGRAPHY; THROMBOGENESIS;

ANIMALS; BLOOD COAGULATION; NITRIC OXIDE; NUCLEOSIDES; NUCLEOTIDES; SWINE;

EID: 77954659148     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328338db27     Document Type: Article

References (37)

1. Kunapuli SP, Daniel JL. P2 receptor subtypes in the cardiovascular system. J Biochem 1998; 336 (Pt 3):513-523.
2. Gachet C. P2 receptors, platelet function and pharmacological implications. Thromb Haemost 2008; 99:466-472.
3. Gachet C. Platelet activation by ADP: the role of ADP antagonists. Ann Med 2000; 32 (Suppl 1):15-20.
4. Lazarowski ER, Boucher RC. UTP as an extracellular signaling molecule. News Physiol Sci 2001; 16:1-5.
5. Seye CI, Kong Q, Yu N, Gonzalez FA, Erb L, Weisman GA. P2 receptors in atherosclerosis and postangioplasty restenosis. Purin Signal 2007; 3:153-162.
6. Yegutkin GG, Samburski SS, Mortensen SP, Jalkanen S, Gonzalez-Alonso J. Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans. J Physiol 2007; 579:553-564.
7. Jabs CM, Ferrell WJ, Robb HJ. Plasma changes in endotoxin and anaphylactic shock (ATP, ADP and creatine phosphorus). Ann Clin Lab Sci 1979; 9:121-132.
8. Cattaneo M, Gachet C. ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 1999; 19:2281-2285.
9. Yao SK, Ober JC, McNatt J, Benedict CR, Rosolowsky M, Anderson HV, et al. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Circ Res 1992; 70:39-48.
10. Gachet C, Hechler B, Leon C, Vial C, Leray C, Ohlmann P, Cazenave JP. Activation of ADP receptors and platelet function. J Thromb Haemost 1997; 78:271-275.
11. Olivecrona GK, Gotberg M, Harnek J, Jacobson KA, Jern S, Erlinge D. The ADP receptor P2Y1 mediates t-PA release in pigs during cardiac ischemia. J Thromb Thrombol 2007; 24:115-122.
12. Levin EG, del Zoppo GJ. Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol 1994; 144:855-861.
13. van den Eijnden-Schrauwen Y, Kooistra T, de Vries RE, Emeis JJ. Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood 1995; 85:3510-3517.
14. Parmer RJ, Mahata M, Mahata S, Sebald MT, O'Connor DT, Miles LA. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway: catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J Biol Chem 1997; 272:1976-1982.
15. Sivula M, Pettila V, Niemi TT, Varpula M, Kuitunen AH. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2009; 20:419-426.
16. Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989; 320:1165-1172.
17. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001; 12:327-337.
18. Freedman JE. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol 2008; 28:s11-s16.
19. Hrafnkelsdottir T, Erlinge D, Jern S. Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in-vivo in man. J Thromb Haemost 2001; 85:875-881.
20. Pearson JD. The control of production and release of haemostatic factors in the endothelial cell. Bailliere's Clin Haematol 1993; 6:629-651.
21. Bouchie JL, Chen HC, Carney R, Bagot JC, Wilden PA, Feener EP. P2Y receptor regulation of PAI-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20:866-873.
22. O'Brien JR, Etherington M, Jamieson S. Refractory state of platelet aggregation with major operations. Lancet 1971; 2:741-743.
23. Baurand A, Eckly A, Bari N, Leon C, Hechler B, Cazenave JP, et al. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2CYC receptors. J Thromb Haemost 2000; 84:484-491.
24. Holme S, Sixma JJ, Wester J, Holmsen H. ADP-induced refractory state of platelets in vitro II: functional and ultra studies on gel-filtered platelets. Scand J Haematol 1977; 18:267-278.
25. Holme S, Holmsen H, Sixma JJ. Proceedings: ADP-induced refractory state of platelets in vitro. Thromb Diast Haemorrh 1975; 34:316.
26. Holme S, Holmsen H. ADP-induced refractory state of platelets in vitro. I: Methodological studies on aggregation in platelet rich plasma. Scand J Haematol 1975; 15:96-103.
27. Takasaki J, Kamohara M, Saito T, Matsumoto M, Matsumoto S, Ohishi T, et al. Molecular cloning of the platelet p2t(ac) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y1 receptor. Mol Pharm 2001; 60:432-439.
28. Cusack NJ, Hourani SM. Partial agonist behaviour of adenosine-5[-O-(2- thiodiphosphate)] on human platelets. Br J Pharm 1981; 73:405-408.
29. Bochsen L, Wiinberg B, Kjelgaard-Hansen M, Steinbruchel DA, Johansson PI. Evaluation of the TEG platelet mapping assay in blood donors. Thromb J 2007; 5:3.
30. Beigi R, Kobatake E, Aizawa M, Dubyak GR. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol 1999; 276:C267-C278.
31. Mangin P, Ohlmann P, Eckly A, Cazenave JP, Lanza F, Gachet C. The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TXA-2 formation is prevented. Thromb Haemost 2004; 2:969-977.
32. Erlinge D, Harnek J, van Heusden C, Olivecrona G, Jern S, Lazarowski E. Uridine triphosphate (UTP) is released during cardiac ischemia. Int J Cardiol 2005; 100:427-433.
33. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80:2787-2796.
34. Amisten S, Braun OO, Johansson L, Ridderstrå le M, Melander O, Erlinge D. The P2Y 13 Met-158-Thr polymorphism, which is in linkage disequilibrium with the P2Y12 locus is not associated with acute myocardial infarction. PLoS One 2008; 3:e1462.
35. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005; 45:246-251.
36. Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM. Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care 2009; 13:R42.
37. Velik-Salchner C, Schnurer C, Fries D, Mussigang PR, Moser PL, Streif W, et al. Normal values for thrombelastography (rotem) and selected coagulation parameters in porcine blood. Thrombo Res 2006; 117:597-602.